List of Studies ( Metabolite:6-Dimethylaminopurine)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002248 | AN003674 | Quantitative multi-Omics analysis of paclitaxel-loaded Poly(lactide-co-glycolide) nanoparticles for identification of potential biomarkers for head and neck cancer | Cultured cells | Human | Cancer | University of Sharjah | AU |
ST002273 | AN003715 | Multi-Omics analysis revealed a significant alteration of critical metabolic pathways due to sorafenib-resistance in Hep3B cell lines | Cultured cells | Human | Cancer | Sharjah Institute for Medical Research | AU |
ST002416 | AN003937 | Proteomics and metabolomics of multiple sclerosis (Part 2) | Brain | Mouse | Multiple sclerosis | Sharjah Institute for Medical Research | AU |
ST002447 | AN003988 | Bioactive molecule(s) of gut bacteria of Crocodile (Crocodylus palustris) as potential pharmaceuticals | Pseudomonas aeruginosa | Bacterial infection | Sharjah Institute for Medical Research | AU | |
ST001935 | AN003145 | Metabolomic profiling of spontaneous macaque model for diabetes mellitus | Blood | Macaque monkey | Diabetes | Xiamen University | Peak area |
ST001935 | AN003145 | Metabolomic profiling of spontaneous macaque model for diabetes mellitus | Liver | Macaque monkey | Diabetes | Xiamen University | Peak area |
ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | Peak Area |
ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |